CPhI & P-MEC China 2019 mere ememe wee nweta nnukwu ihe ịga nke ọma maka ụlọ ọrụ ọgwụ Changzhou!

Njikwa R&D

IMG_1690

Zuru oke R&D ikpo okwu

Wuru Pharmaceutical Research Institute, inwe a post-doctoral resreach mobile ọdụ, imekota akụrụngwa n'ụzọ zuru ezu, accelerating mmepe mmepe nke oru ngo, na-eme ka mmepe usoro nke oru ngo.

IMG_1691

Otu R&D kwụ ọtọ dị elu

N'ịbụ ndị otu R&D dị elu nwere120ndị mmadụ, gụnyere49Master degree kacha nta,59nzere bachelọ, na18onye injinia ukwu.

IMG_1656

Ntinye ego R&D na-aga n'ihu

Ntinye ego R&D na-ekpuchi olu ire ahịa 8% kwa afọ, ma nye nkwado ego na-aga n'ihu maka iwelite ikike R&D dị elu yana nkwalite akụrụngwa R&D.

IMG_163911

Kpochapụ ntụzịaka nyocha na mmepe

R&D agbakwunyere maka API na usoro, wulitela ikpo okwu R&D ewepụtara agbatị;ịzụlite uru nke API R&D, ịma aka patent ma wuo ihe mgbochi teknụzụ.

API R&D

Họrọ njirimara API R&D atụmatụ nke nwere ahịa na-ekwe nkwa, obere ụlọ ọrụ R&D na-etinye aka, nnukwu ihe isi ike maka njikọ ahụ.

CPF214

Endometriosis

Emecha ndebanye aha DMF na Maachị 2021

CPF219

Ọrịa cancer akpa nwa

Emecha ndebanye aha DMF na Jun. 2021

CPF219

Ọrịa flu

Emecha ndebanye aha DMF na Ọkt. 2021

CPF216

Ọrịa ara ara

Emecha ndebanye aha DMF na Jun. 2021

CPF227

B ọrịa leukemia

Emecha ndebanye aha DMF na Dec. 2021

CPF231

HIV

Emecha ndebanye aha DMF na Jun. 2021

njikwa mma

Ruo 1984, akwadoro nyocha US FDA maka16ugboro, gụnyere API13ugboro, na okokụre dosages3ugboro.

1984

Hydrochlorothiazide/

Doxycycline / Rosuvastatin

ugboro

2016

Ọgwụ nke Rosuvastatin

2017

Rosuvastatin bụ ọgwụ capsule nke doxycycline

2019

Nyocha Nantong Chanyoo oge niile
Ụlọ ọrụ Changzhou Pharma.Nyocha oge
Levethracetam kwagidere ntọhapụ mbadamba

Quality management1

Atụmatụ18Ọrụ nlebanya na-agbanwe agbanwe nke akwadoro4, na6A na-akwado ọrụ ngo.

Quality management2

Usoro njikwa ogo mba ụwa dị elu etinyela ntọala siri ike maka ire ahịa.

Quality management3

Nlekọta dị mma na-aga n'ihu na usoro ndụ nke ngwaahịa ahụ niile iji hụ na ịdịmma na mmetụta ọgwụgwọ.

Quality management4

Ndị otu Regulatory Affairs ndị ọkachamara na-akwado ịdịmma chọrọ n'oge ngwa na ndebanye aha.

njikwa mmepụta

Akụrụngwa emelitere

Ntinye ego na-aga n'ihu na ịgbasawanye na-akpalite banyere ngwá ọrụ mmepụta na mgbanwe akpaka, bụ nke mepụtara nrụpụta mmepụta ihe, kwadoro nkwụsi ike nke àgwà ngwaahịa, nweta njikwa dabere na ọnụ ahịa na-ebelata na uru na-abawanye.

cpf5
cpf6

Ahịrị nkwakọ ngwaahịa Korea Countec

cpf7
cpf8

Taiwan CVC ahịrị nkwakọ ngwaahịa

cpf9
cpf10

Line CAM Board Ịtali

cpf11

Igwe na-akpakọrịta Fette German

Nrụpụta anwụ pụrụiche mere ka nrụgide oge jigide okpukpu abụọ, izi ezi dị elu, ike mgbawa ka mma na ogo mgbawa.

cpf12

Ihe nchọpụta mbadamba ihe ngosi nke Japan

A na-enyocha ọdịdị ọdịdị nke ngwaahịa ahụ site na ọka site na ọka na ọsọ nke 100,000 iberibe / hour, na mkpochapụ bụ 99.99%.

cpf14-1

Ụlọ njikwa DCS

Emelitere ọkwa akpaaka nke mmepụta ogbako API, mbelata njikwa ọrụ na ọnụ ahịa, yana nkwụsi ike nke ịdịmma.


Oge nzipu: Ọktoba 14-2020